Omnicell reported a decrease in GAAP revenues to $199.6 million, a net loss of $4.3 million, or $0.10 per diluted share, for the second quarter of 2020. The company is navigating challenges related to the COVID-19 pandemic but sees positive indicators for future growth.
GAAP revenues for the second quarter of 2020 were $199.6 million, down 8.2% from the second quarter of 2019.
Second quarter 2020 GAAP net loss was $4.3 million, or $0.10 per diluted share, compared to GAAP net income of $16.0 million, or $0.37 per diluted share, for the second quarter of 2019.
Non-GAAP net income for the second quarter of 2020 was $15.9 million, or $0.37 per diluted share, compared to non-GAAP net income of $28.7 million, or $0.67 per diluted share, for the second quarter of 2019.
The company expects product bookings and revenues will increase sequentially through the third and fourth quarters of 2020.
For the third quarter of 2020, Omnicell expects non-GAAP total revenues to be between $204 million and $212 million and non-GAAP earnings to be between $0.44 and $0.52 per share.
Analyze how earnings announcements historically affect stock price performance